Results from a randomized trial showed that step therapy for diabetic macular edema with lower-priced bevacizumab followed by pricier aflibercept, when needed, works as well as aflibercept monotherapy. Medscape Medical News
Tag: Diabetes & Endocrinology
Diabetic Retinopathy Risk, Severity Show Socioeconomic Links
Low income and type of health insurance was associated with an increased prevalence of medical risk factors for diabetic retinopathy as well as the risk for vision-threatening disease. First Look
Retinopathy Risk in Kids Higher in Type 2 Than Type 1 Diabetes
Children diagnosed with type 2 diabetes appear significantly more likely to develop retinopathy and other ocular complications than children diagnosed with type 1 diabetes. Medscape Medical News
Retinopathy Risk Higher in Young-Onset T2D, More So in Men
Men diagnosed with type 2 diabetes by the age of 40 years appear significantly more likely to develop retinopathy than men who are diagnosed at an older age. Medscape Medical News
Alarming Number of Youths With Type 2 Diabetes Have Eye Damage
Diabetic retinopathy, a complication that can eventually lead to sight loss, was found in nearly half of young adults with type 2 diabetes. WebMD Health News
Adding Statins to Steroids in Thyroid Eye Disease Improves Outcomes
The drugs were linked to improvements in Graves’ orbitopathy, even in people without high LDL-cholesterol; anti-inflammatory effects a possible explanation. Medscape Medical News
Do Anti-VEGF Injections for Diabetic Retinopathy Impact Mortality?
A signal for higher mortality in patients with diabetic retinopathy using anti-VEGF inhibitors was seen in a new study, but this needs to be looked at more rigorously, says an expert. Medscape Medical News
Even Inactive Thyroid Eye Disease Adversely Impacts Patients
Patients with inactive thyroid eye disease continue to have eye symptoms as well as poor mental health and quality of life. Medscape Medical News
Only 1 in 3 US Adults With Diabetes Receive ADA-Recommended Care
In 2017-2018, only one in three received all of five care elements recommended by the American Diabetes Association. Medscape Medical News
Surgery Equals Drug Tx for Bleeding in Diabetic Retinopathy
A comparison of vitrectomy and anti-VEGF injections to treat vitreous hemorrhage in patients with proliferative diabetic retinopathy shows the pros and cons of each, but effects are similar. Medscape Medical News
Diabetic Retinopathy May Predict Greater Risk of COVID-19 Severity
‘Our study reports the first description of diabetic retinopathy as a potential risk factor for poor COVID-19 outcomes,’ say the authors of a new study. Medscape Medical News
Teprotumumab Eases Thyroid Eye Disease in All, Including Smokers
Approved by the FDA in January 2020, the monoclonal antibody appears to reduce eye bulging regardless of age, gender, country, or smoking status. Medscape Medical News
Loss of Tear Glands Linked to Suboptimal Diabetes Control
Phenomenon underlies the connection between diabetes and dry eye, could be used as a biomarker for suboptimal glucose control. Medscape Medical News
FDA Approves First Treatment for Thyroid Eye Disease
The monoclonal antibody teprotumumab reduces proptosis and related eye problems in patients with thyroid-associated ophthalmopathy. FDA Approvals
Teprotumumab Improves Bulging, QOL, in Thyroid Eye Disease
The pooled results of phase 2 and 3 clinical trials could pave the way for first approved drug for thyroid eye disease. Medscape Medical News
Teprotumumab Improves Bulging, QOL in Thyroid Eye Disease
The pooled results of phase 2 and 3 clinical trials could pave the way for first approved drug for thyroid eye disease. Medscape Medical News
Further Debate on T3 + T4 Combination Therapy at ATA Meeting
The 89th annual meeting gets underway this week, with anaplastic thyroid cancer guidelines and combination T3 /T4 therapy among the highlights being discussed. Medscape Medical News
‘Remarkable’ Findings From Da Qing Diabetes Prevention Trial
Delaying diabetes by 6 years in this study further reinforces "the thesis that the longer the progression to diabetes can be delayed, the fewer the complications," say Chinese researchers. Medscape Medical News
Terrifying Complications in 20 Year Olds With Type 2 Diabetes
"I think we need to recognize that…in these younger kids we probably need even more aggressive management than many adults with type 2 diabetes," says the lead author of the TODAY-2 study. Medscape Medical News
‘Alarming’ Complications in 20-Year-Olds With Type 2 Diabetes
‘I think we need to recognize that…in these younger kids we probably need even more aggressive management than many adults with type 2 diabetes,’ says the lead author of the TODAY-2 study. Medscape Medical News